Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses. (January 2022)

Record Type:: Journal Article
Title:: Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses. (January 2022)
Main Title:: Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses
Authors:: Schmiedeberg, Kristin
Vuilleumier, Nicolas
Pagano, Sabrina
Albrich, Werner C
Ludewig, Burkhard
Kempis, Johannes von
Rubbert-Roth, Andrea
Abstract:
Is Part Of:: Lancet. Volume 4:Number 1(2022)
Journal:: Lancet
Issue:: Volume 4:Number 1(2022)
Issue Display:: Volume 4, Issue 1 (2022)
Year:: 2022
Volume:: 4
Issue:: 1
Issue Sort Value:: 2022-0004-0001-0000
Page Start:: e11
Page End:: e13
Publication Date:: 2022-01
Subjects:: Rheumatology -- periodicals
616.72305
Journal URLs:: https://www.thelancet.com/journals/lanrhe/issues#decade=loi_decade_201 ↗
https://www.sciencedirect.com/journal/the-lancet-rheumatology ↗
http://www.sciencedirect.com/ ↗
DOI:: 10.1016/S2665-9913(21)00328-3 ↗
Languages:: English
ISSNs:: 2665-9913
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 20301.xml